Item 7.01 Regulation FD Disclosure.

Relay Therapeutics, Inc. (the "Company") will be conducting meetings with participants attending the 40th Annual J.P. Morgan Healthcare Conference (the "Conference") during the week of January 10, 2022. A copy of the slides to be presented by the Company at the Conference is furnished as Exhibit 99.1 to this Current Report on Form 8-K, which is incorporated herein by reference.

The information in this Item 7.01, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Exhibits.



99.1      40th Annual J.P. Morgan Healthcare Conference Company Presentation,
        dated January 2022, furnished herewith.
104     Cover Page Interactive Data File (embedded within Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses